R
Rocket Pharmaceuticals, Inc. (RCKT)
3.77
0.00 (0.00%)
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
3.77
0.00 (0.00%)
This stock has a consensus price target of $33.34 based on the ratings of 17 analysts. The high is $263.00 and the low is $2.50.
| Maqsad | Min. maqsadli narx | O‘rtacha maqsadli narx | Maks. maqsadli narx |
|---|---|---|---|
| Narx | $ 2.5 | $ 33.34 | $ 263 |
| O’zgarish | -33.69% | 784.35% | 6876.13% |
| Sana | O‘sish/pasayish potensiali | Tahlilchi firmasi | Maqsadli narx | Reyting o‘zgarishi | Reyting |
|---|---|---|---|---|---|
| 2026-03-27 | 191.78% | Chardan Capital | $11 → $11 | Maintains | Buy |
| 2026-03-02 | -20.42% | Goldman Sachs | $2 → $3 | Maintains | Sell |
| 2026-02-27 | 165.25% | Cantor Fitzgerald | $8 → $10 | Maintains | Overweight |
| 2025-11-18 | 112.2% | B of A Securities | $10 → $8 | Maintains | Buy |
| 2025-11-18 | 6876.13% | JP Morgan | $261 → $263 | Downgrades | Overweight → Underweight |